The bradykinin (BK) B 2 receptor (B 2 R) is G protein coupled and phosphorylated upon agonist stimulation; its endocytosis and recycling are documented. We assessed the effect of drugs that affect the cytoskeleton on B 2 R cycling. These drugs were targeted to tubulin (paclitaxel, or the novel combretastatin A-4 mimetic 3,4,5-trimethoxyphenyl-4-(2-oxoimidazolidin-1-yl)benzenesulfonate Consistent with the displacement of cargo along specific cytoskeletal elements, Rab5-associated progression of the endocytosed BK B 2 R follows microtubules toward their (-)end, while its recycling progresses along actin fibers to the cell surface. However, tubulin ligands do not suppress the tested desensitization or resensitization mechanisms of the B 2 R.
Introduction
Bradykinin (BK) is a blood-derived nonapeptide that is a prominent cardiovascular regulator and also functions as a mediator of inflammation [1] . The BK B 2 receptor (B 2 R) is a G protein-coupled receptor (GPCR) possessing a domain in its C-terminal tail that is phosphorylated by GPCR kinases upon agonist stimulation. Thus, the B 2 R combines with either type of non-visual -arrestins and the ligand-B 2 R--arrestin complex gets translocated into endosomes [1, 2] . The fusion protein B 2 Rgreen fluorescent protein (B 2 R-GFP) -arrestins conjugated to fluorescent proteins and BK sequences that were extended with fluorophores were instrumental in modeling the BK-induced endocytosis, but also its recycling to the cell surface and the persistence of the ternary agonistreceptor--arrestin complexes in intracellular structures [3] [4] [5] (and literature cited herein).
Fluorescent BK analogs are rapidly transported by the B 2 R into Rab5-and early endosome autoantigen 1 (EEA1)-positive early endosomes and are later sorted in Rab7-positive late endosomes [3, 4] . However, the BK-stimulated B 2 Rs are essentially completely recycled to the cell surface as a function of time, unless the agonist has an altered structure that confers resistance to proteolytic breakdown. In this case, the length of the B 2 R internalization and the duration of signaling are remarkably prolonged, and the secondary down-regulation of the receptors becomes prominent [2, 5] .
Rab proteins are a family of small GTPases that organize vesicular trafficking in the cells by interacting with multiple molecular partners [6] . Rab5 and EEA1 are believed to be required for the transition of endosomes from the cell surface to the depth of the cytosolic space by traveling along the microtubules toward their minus end (that opposed to the cell surface) [6] . Since the agoniststimulated B 2 R is colocalized with Rab5 and EEA1, its inward movement is predicted to proceed along microtubules. On the other hand, receptors sorted for recycling could travel along with Rab11 (as shown for the cannabinoid CB 2 receptor 2 -adrenoceptors) [7, 8] along the actin cytoskeleton [6] . Thus, the rapid recycling of the interleukin-8 receptors CXCR1 and CXCR2 2 - adrenoceptors are inhibited by cytochalasin D, an actin filament-disrupting drug [8, 9] . Rab4 has also a role in the recycling of internalized cargo to the cell surface (tra 2 -adrenoceptor) [10, 11] . Whether this general model applies to the BK B 2 R has been tested by exploiting, along with cytochalasin D, ligands of microtubules that act in complementary manner:
paclitaxel (Taxol), that stabilizes microtubules, and a novel combretastatin A-4 mimetic that depolymerizes microtubules. The latter compound, IMZ-602, is a high potency representative of a family of drugs selectively targeted at the colchicine-binding site of tubulin [12] . Cytoskeletonbinding agents have been used mainly along visualization tools at specific times during BK-induced receptor cycling to isolate their effects on the endocytosis, progression and recycling.
Materials and methods

Drugs
The synthesis and properties of the tubulin-binding drug 3,4,5-trimethoxyphenyl-4-(2-oxoimidazolidin-1-yl)benzenesulfonate have been reported by Fortin et al. [12] . This compound (45 in the original publication) will be designated by the code IMZ-602. This drug inhibited the growth of tumor-derived cell lines with IC 50 values below 10 nM and morphologically disrupted the tubulin cytoskeleton at 4 nM (immunofluorescence of -tubulin in M21 cells) [12] . FTC-B-9972 
Data analysis
The subcellular distribution of elements of the agonist-B 2 R--arrestin complex was assigned to one of the two following categories: either peripheral (labeling at the plasma membrane or close to it, within vesicles possibly attached or juxtaposed to the plasma membrane) or non-peripheral, the latter being the typical B 2 R distribution 30 min after agonist stimulation. These qualitative groupings, comparison test were used to analyze radioligand binding data.
Results
Microscopic study of the endocytosis process
HEK 293 cells that stably express B 2 R-GFP exhibit a sharply defined fluorescence associated with the plasma membrane in more than 80% of evaluated cells ( organelles that were still polymorphic, but often quite large (Fig. 3) . The third element of the internalized complex organized around the B 2 R is the agonist ligand. FTC-B-9972, a recently described fluorescent B 2 R agonist resistant to endosomal breakdown [4] , was exploited in HEK 293a cells that transiently expressed myc-B 2 R (Fig. 4 ). Cells stimulated with FTC-B-9972 contained more or less defined fluorescent endosomal structures that could be very small and look like a cells treated with fluorescent transferrin [18] ) and the endosomal distribution was rarely predominantly peripheral (Fig. 4) . However, in cells pretreated with IMZ-602, the peripheral distribution of fluorescent organelles was again sharply increased.
Therefore, the intracellular translocation of all elements of the ligand-receptor--arrestin triad is inhibited by tubulin depolymerization.
An N-terminally myc-tagged B 2 R (myc-B 2 R) can be labeled in intact cells using anti-myc monoclonal antibodies and the receptor stimulated with BK transports these antibodies into endosomal structures [16] . A variant of this system was exploited to determine whether the pharmacologic ligands of tubulin block the endocytosis of the B 2 R by using an AlexaFluor488- 
Effect of cytochalasin D on the recycling process
The recycling of B 2 R-GFP is conveniently assessed 3 h after stimulation with BK, a fragile peptide that is rapidly cleared by different pathways in both the serum-containing culture medium and in endosomes [5] (Fig. 6, top 
Discussion
We investigated the role of cytoskeletal elements on the cycling of the BK B 2 Rs using mainly pharmacological and morphological approaches. Internalized B 2 R-GFP is colocalized with transferrin, but not low-density lipoprotein, in HEK 293 cells stimulated with BK [18] , suggesting that this model receptor molecule is confined to recycling endosomes under these conditions.
Further, expression of GDP-locked Rab5 reportedly inhibited transferrin endocytosis [19] and GTP- The tubulin ligands, either depolymerizing (IMZ-602) or stabilizing (paclitaxel), exerted a similar effect that can be characterized as the inhibition of the progression of the ternary complex from the cell surface, but not necessarily the inhibition of endocytosis itself since endosomal structures containing any of the 3 members of the triad (the ligand, the receptor or the arrestin) were observed just below the plasma membrane surface (Figs. 2-4 ). An antibody-based approach confirmed that IMZ-602 or paclitaxel pretreatment did not prevent BK-induced clearing of most cell surface myc-B 2 Rs (Fig. 5) . The alternate tubulin ligand nocodazole failed to inhibit the interleukin-8-induced endocytosis of CXCR1 and -2 in another study [9] , consistent with current findings, that therefore limit the role of microtubules in GPCR cycling to intracellular progression. Overexpression of the dominant negative (GDP-locked) version of Rab 5 fully reproduced the effect of tubulin ligands on B 2 R-GFP cycling (Fig. 8 ), in line with the model outlined above. In a previous study, the morphological effect of GDP-2 -adrenoceptors was similar to that observed with B 2 R-GFP: receptor-containing vesicles were said to remain in either close juxtaposition or attached to plasma membrane [11] . However, the receptors remained accessible to extracellular antibodies in that study, which may be a subtle differential effect of dominant negative
Rab5 vs. that of tubulin ligands.
The recycling of endocytosed cannabinoid CB 2 receptors 2 -adrenoceptors has been shown to be dependent on Rab11 [7, 8] . GDP-locked Rab11 also prevents the recycling of vasopressin V 2 , somatostatin 3 and CXCR2 [20] [21] [22] . The actin cytoskeleton is currently considered as the substrate for this form of vesicular translocation [6] . Thus, cytochalasin D inhibited the recycling of agoniststimulated CXCR1 and -1B -adrenoceptors [9, 23] . Cytoskeletal elements that support Rab4-mediated cargo translocation are not defined as well as those related to Rab11 or Rab5.
Occasional discrepancies were observed in exploited models of B 2 R endocytosis/recycling. Firstly, BK-induced internalization of the transiently expressed myc-B 2 R is apparently more complete than that of stably expressed B 2 R-GFP, based on the residual fluorescence apparently coincident with plasma membranes in BK-treated cells, whether or not co-treated with tubulin ligands (Fig. 2) . This discrepancy is probably related to the ~6-fold higher expression of B 2 R-GFP relative to that of myc- Fig. 2 ). The morphological category may be oversensitive to the cytosolic retention of a fraction of fluorescent endosomes, thus providing a somewhat amplified assessment.
Tubulin ligands do not inhibit BK-induced B 2 R internalization (Fig. 5) or association of the B 2 R to -arrestin (Fig. 3) . Further, B 2 R recycling to the cell surface is not altered by these drugs (Fig. 6 ).
Therefore, no major effect of tubulin inhibitors on B 2 R signaling is predicted as desensitization and ligands, developed as anti-cancer agents [12] , are cytotoxic. Thus, the present study was limited to a pre-apoptotic time window. Further, the depolymerizing agent IMZ-602 and the microtubulestabilizing drug paclitaxel exerted similar effects on all accounts when both were tested in parallel, a finding supporting that dynamic microtubule remodeling is necessary for cargo progression mediated by Rab5.
In summary, consistent with the displacement of cargo along specific cytoskeletal elements, Rab5-associated progression of the endocytosed BK B 2 Rs follows microtubule toward their (-) end, while its Rab11-mediated recycling may progress along actin fibers to the cell surface (see Fig. 9 , schematic representation). Based on the effect of the dominant negative constructions, Rab4 also seems to exert a role in the recycling. While similar approaches have been applied to other GPCRs, they have never been applied before to the BK B 2 R. However, tubulin ligands do not suppress the tested desensitization or resensitization mechanisms of the B 2 R. peripheral fluorescence: 
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